befol has been researched along with Arrhythmia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartashevich, VV; Galenko-Iaroshevskiĭ, PA; Kanorskiĭ, SG; Khankoeva, AI; Skibitskiĭ, VV; Uvarov, AV | 1 |
| Bartashevich, VV; Galenko-Iaroshevskiĭ, PA; Galygo, DS; Khankoeva, AI; Reznikov, AIu; Uvarov, AV | 1 |
| Cherednik, IL; Galenko-Iaroshevskiĭ, PA; Khankoeva, AI; Popov, PB; Sheĭkh-Zade, IuR; Sirotenko, DV; Turovaia, AIu; Uvarov, AV | 1 |
| Meerson, FZ; Skibitskiĭ, VV | 1 |
4 other study(ies) available for befol and Arrhythmia
| Article | Year |
|---|---|
[Possibilities of correcting adverse effects of anti-arrhythmia agents].
Topics: Anti-Arrhythmia Agents; Antidepressive Agents; Arrhythmias, Cardiac; Benzamides; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Moricizine; Morpholines; Myocardial Ischemia; Succinates; Succinic Acid; Tachycardia, Paroxysmal; Ventricular Premature Complexes | 1996 |
[Comparative anti-arrhythmia activity of befol, lidocaine, and bonnecor].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzamides; Dibenzazepines; Dogs; In Vitro Techniques; Lethal Dose 50; Lidocaine; Male; Morpholines; Rats; Rats, Wistar | 1996 |
[Anti-arrhythmia activity of befol, sufan, mexidol, and T3-146 in combination with other anti-arrhythmia agents].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Benzamides; Cats; Coronary Disease; Drug Synergism; Morpholines; Myocardial Reperfusion Injury; Picolines; Piracetam; Succinates; Tryptophan | 1998 |
[Comparative anti-arrhythmia effectiveness of activators of body stress-limiting systems in patients with arrhythmia].
Topics: Adult; Aged; Angina Pectoris; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzamides; Benzodiazepines; Benzodiazepinones; Coronary Disease; Female; Humans; Male; Middle Aged; Morpholines; Neurocirculatory Asthenia; Receptors, GABA-A; Stress, Physiological; Valproic Acid | 1992 |